Mumbai-based pharmaceutical company Lupin revealed that it has reached an agreement with US-based Onset Dermatologics.

Stating that it will help expand the market for Locoid Lotion, Onset Dermatologics President Bob Moccia said, “This partnership will give pediatricians greater opportunity to utilize Locoid lotion in their patients while Onset maintains its focus on promoting Locoid to the dermatology community. We are confident that Locoid will continue to be the most prescribed mid-potency steroid brand in the U.S.”
Source-Medindia